Grant
$600k
Australian company awarded $600,000 to commercialise rapid Covid test
Diagnostics firm Zip Diagnostics received a $600,000 federal grant through the BioMedTech Horizons program to commercialise rapid Covid-19 tests built on Axxin platforms.